株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

米国の脳内酸素飽和度モニタリング市場の分析

Cerebral Oximetry Monitoring Market Report | United States | 2019-2025 | MedCore

発行 iData Research Inc. 商品コード 370976
出版日 ページ情報 英文 496 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.28円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の脳内酸素飽和度モニタリング市場の分析 Cerebral Oximetry Monitoring Market Report | United States | 2019-2025 | MedCore
出版日: 2019年01月01日 ページ情報: 英文 496 Pages
概要

当レポートでは、米国における脳内酸素飽和度モニタリング装置の市場について分析し、技術・製品の概要や、全体的な市場規模の実績値・予測値、製品別 (モニター・センサー等) の詳細動向、主な市場促進・抑制要因、主要企業の市場シェアなどについて調査・推計しております。

エグゼクティブ・サマリー

米国の患者モニタリング装置・機器市場の概要

競争分析

市場の傾向

分析対象市場

市場の発展

主要レポートの更新状況

過去のバージョン

調査手法

  • 調査範囲
  • IDATAの9段階の分析方法

脳内酸素飽和度モニタリング市場

  • イントロダクション
    • 酸素飽和度の測定技術
    • 市場への影響度
  • 市場概要
  • 市場の分析と予測
    • 脳内酸素飽和度モニター市場
    • 脳内酸素飽和度センサー市場 (全体)
      • 成人用脳内酸素飽和度センサー
      • 小児用脳内酸素飽和度センサー
  • 市場促進・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 企業別市場シェアの分析

略語一覧

図表

LIST OF CHARTS

  • Chart 1 1: Patient Monitoring Equipment Market by Segment, U.S., 2015 - 2025 3
  • Chart 1 2: Patient Monitoring Equipment Market Overview, U.S., 2018 & 2025 3
  • Chart 2 1: Cerebral Oximetry Monitoring Market by Segment, U.S., 2015 - 2025 38
  • Chart 2 2: Cerebral Oximetry Monitoring Market Breakdown, U.S., 2018 39
  • Chart 2 3: Cerebral Oximetry Monitoring Market Breakdown, U.S., 2025 40
  • Chart 2 4: Cerebral Oximetry Monitor Market, U.S., 2015 - 2025 43
  • Chart 2 5: Total Cerebral Oximetry Sensor Market by Segment, U.S., 2015 - 2025 46
  • Chart 2 6: Total Cerebral Oximetry Sensor Market, U.S., 2015 - 2025 48
  • Chart 2 7: Adult Cerebral Oximetry Sensor Market, U.S., 2015 - 2025 50
  • Chart 2 8: Pediatric Cerebral Oximetry Sensor Market, U.S., 2015 - 2025 52
  • Chart 2 9: Leading Competitors, Cerebral Oximetry Monitoring Market, U.S., 2018 58

LIST OF FIGURES

  • Figure 1 1: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (1 of 2) 4
  • Figure 1 2: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (2 of 2) 5
  • Figure 1 3: Companies Researched in this Report, U.S., 2018 (1 of 3) 6
  • Figure 1 4: Companies Researched in this Report, U.S., 2018 (2 of 3) 7
  • Figure 1 5: Companies Researched in this Report, U.S., 2018 (3 of 3) 8
  • Figure 1 6: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (1 of 2) 9
  • Figure 1 7: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (2 of 2) 10
  • Figure 1 8: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (1 of 3) 11
  • Figure 1 9: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (2 of 3) 12
  • Figure 1 10: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (3 of 3) 13
  • Figure 1 11: Patient Monitoring Equipment Markets Covered, U.S., 2018 (1 of 5) 14
  • Figure 1 12: Patient Monitoring Equipment Markets Covered, U.S., 2018 (2 of 5) 15
  • Figure 1 13: Patient Monitoring Equipment Markets Covered, U.S., 2018 (3 of 5) 16
  • Figure 1 14: Patient Monitoring Equipment Markets Covered, U.S., 2018 (4 of 5) 17
  • Figure 1 15: Patient Monitoring Equipment Markets Covered, U.S., 2018 (5 of 5) 18
  • Figure 1 16: Key Report Updates 19
  • Figure 1 17: Version History 19
  • Figure 2 1: Cerebral Oximetry Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 37
  • Figure 2 2: Cerebral Oximetry Monitor Market, U.S., 2015 - 2025 42
  • Figure 2 3: Total Cerebral Oximetry Sensor Market by Segment, U.S., 2015 - 2025 (US$M) 45
  • Figure 2 4: Total Cerebral Oximetry Sensor Market, U.S., 2015 - 2025 47
  • Figure 2 5: Adult Cerebral Oximetry Sensor Market, U.S., 2015 - 2025 49
  • Figure 2 6: Pediatric Cerebral Oximetry Sensor Market, U.S., 2015 - 2025 51
  • Figure 2 7: Drivers and Limiters, Cerebral Oximetry Monitoring Market, U.S., 2018 55
  • Figure 2 8: Leading Competitors, Cerebral Oximetry Monitoring Market, U.S., 2018 57
  • Figure 4 1: Press Release Summary 62
目次
Product Code: iDATA_USPME19_MC_COX

Cerebral oximetry is a non-invasive technology that continuously monitors cerebral tissue oxygen saturation through optical techniques. More specifically, trans-cranial cerebral oximetry is a method to detect cerebral hypoxia and to avoid cerebral dysfunctions. Brain tissue saturation measurements are critical to monitoring the level of cerebral hypoperfusion. When coupled with pulse oximetry, cerebral oxygen saturation readings allow healthcare professionals to establish the effects of cerebral metabolism changes regionally and balance local cerebral oxygen supply.

As market penetration improves, sustainable expansion will depend on the rate of use of cerebral oximetry monitoring technologies in a variety of indicated procedures. Efforts to increase levels of awareness regarding the cost and outcome benefits of employing cerebral oximetry monitoring are expected to foster improved uptake and support an optimistic forecast.

Table of Contents

TABLE OF CONTENTS I

LIST OF FIGURES XVIII

LIST OF CHARTS XIX

EXECUTIVE SUMMARY 1

U.S. PATIENT MONITORING EQUIPMENT MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 9

MARKET DEVELOPMENTS 11

MARKETS INCLUDED 14

KEY REPORT UPDATES 19

VERSION HISTORY 19

RESEARCH METHODOLOGY 20

    • Step 1: Project Initiation & Team Selection 20
    • Step 2: Prepare Data Systems and Perform Secondary Research 23
    • Step 3: Preparation for Interviews & Questionnaire Design 25
    • Step 4: Performing Primary Research 26
    • Step 5: Research Analysis: Establishing Baseline Estimates 28
    • Step 6: Market Forecast and Analysis 29
    • Step 7: Identify Strategic Opportunities 31
    • Step 8: Final Review and Market Release 32
    • Step 9: Customer Feedback and Market Monitoring 33

CEREBRAL OXIMETRY MONITORING MARKET 34

  • 2.1 INTRODUCTION 34
    • 2.1.1 Oximetry Technologies 35
    • 2.1.2 Market Impacts 35
  • 2.2 MARKET OVERVIEW 36
  • 2.3 MARKET ANALYSIS AND FORECAST 41
    • 2.3.1 Cerebral Oximetry Monitor Market 41
    • 2.3.2 Total Cerebral Oximetry Sensor Market 44
      • 2.3.2.1 Adult Cerebral Oximetry Sensor Market 49
      • 2.3.2.2 Pediatric Cerebral Oximetry Sensor Market 51
  • 2.4 DRIVERS AND LIMITERS 53
    • 2.4.1 Market Drivers 53
    • 2.4.2 Market Limiters 53
  • 2.5 COMPETITIVE MARKET SHARE ANALYSIS 56

ABBREVIATIONS 59

APPENDIX: COMPANY PRESS RELEASES 62

  • 4.1 INTRODUCTION 62
  • 4.2 PRESS RELEASES 62
    • 4.2.1 Draeger Medical 63
      • 4.2.1.1 First half of 2018: Drager increases net sales 63
      • 4.2.1.2 New HealthTrust Agreement Covers Drager's Line of Anesthesia Solutions 64
      • 4.2.1.3 Drager and ICON Prepared to Support Hospitals with Ventilators During Times of Crisis 65
      • 4.2.1.4 Drager First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems 65
      • 4.2.1.5 Drager Infinity M300 Monitor Now Features FIPS Security 66
      • 4.2.1.6 Drager First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems 68
      • 4.2.1.7 Drager to Discuss Alarm Management and Strategies for Eliminating "Alarm Fatigue" at HIMSS16 69
    • 4.2.2 Edwards Lifesciences 71
      • 4.2.2.1 Edwards Lifesciences Reports Second Quarter Results 71
      • 4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S. 73
      • 4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results 74
      • 4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 77
      • 4.2.2.5 Edwards Acquires Harpoon Medical 79
      • 4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance 79
      • 4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results 80
      • 4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio 83
      • 4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator 85
      • 4.2.2.10 Edwards Lifesciences Reports Second Quarter Results 86
      • 4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors 86
      • 4.2.2.12 Edwards Lifesciences Reports First Quarter Results 87
      • 4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of Directors 89
      • 4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results 90
    • 4.2.3 Fukuda Denshi 94
      • 4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. A High Performance Color Portable Ultrasound Unit Designed for a Wide Array of Specialty Markets 94
      • 4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi USA Inc. and Amerinet Choice License and Supply Agreement 94
    • 4.2.4 GE Healthcare 96
Back to Top